Qube Research & Technologies LTD Cara Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 44,633 shares of CARA stock, worth $20,531. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,633
Previous 66,610
32.99%
Holding current value
$20,531
Previous $17,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$1.03 Million0.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$782,9700.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$715,8750.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$511,9990.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$510,1080.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $24.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...